Leith Greenslade is Co-founder and Coordinator of the Every Breath Counts Coalition, an alliance of 100 organizations from the public, private, and non-profit sectors working together to help low- and middle-income country governments reduce deaths from pneumonia. Every Breath Counts is a flagship initiative of JustActions, which Leith launched in 2016 to mobilize global action around ten initiatives with the power to accelerate progress to a more just world rapidly, sustainably, and irreversibly. She is a proud member of the Every Woman, Every Child movement and has served as a Vice Chair with the MDG Health Alliance, a network of leaders committed to accelerating the achievement of global health goals. Deeply committed to the power of new ideas, Leith established two global innovation teams to improve the health of vulnerable children, is a Board member of TEAMFund, and an adviser to several global health and development organizations. She has served on the US Board of Gavi, the Vaccine Alliance and in several positions with the Australian Government, including with the Deputy Prime Minister and Minister for Health, the Leader of the Federal Opposition, and the Shadow Minister for Social Security and the Status of Women. Leith holds a Masters in Public Administration from the Harvard Kennedy School, a Masters in Business Administration from the Chinese University of Hong Kong and a First Class Honors Degree from the University of Queensland.

Dr. Grijalva is a Professor in the Division of Pharmacoepidemiology, Department of Health Policy at Vanderbilt University Medical Center. He maintains appointments at the Vanderbilt Epidemiology Center, the Center for Health Services Research, the Institute for Global Health, the Center for Data Science, and the Veterans Affairs Tennessee Valley Geriatric Research Education and Clinical Center. Dr. Grijalva’s research focuses on the study of medications and their association with serious infections, and the study of vaccine-preventable diseases - especially pneumococcal, influenza and SARS-CoV-2 infections - and the evaluation of vaccination programs. His research portfolio includes retrospective studies, as well as prospective domestic and international cohort studies that examine the burden of respiratory infections, the interaction between respiratory viruses and bacteria, the impact of vaccination and the transmission of respiratory pathogens within households. His work is funded by the National Institutes of Health, the Centers for Disease Control and Prevention, the Agency for Healthcare Research and Quality, the Food and Drug Administration, among other sources. He has published more than 240 peer-reviewed articles.